3 unknown, 1 completed. 4 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Unknown 3, Completed 1 |
Follow Endostar: new trials by email Literature Review of Endostar trials Research Report on Endostar
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| PK Study for Endostar Continuous Intravenous Infusion in NSCLC Patients With 1st-line Platinum Based Chemotherapy Endostar, use the vein pump to pump drugs, combination therapy - Advanced or Metastatic NSCLC | Phase 1 | Unknown | Jiangsu Simcere Pharmaceutical Co., Ltd. | 24 | 2021-07-30 | 2021-06-30 |
| Study of Endostar Subcutaneous Injection in NSCLC Endostar, Chemotherapy - NSCLC | Phase 1 | Unknown | Jiangsu Simcere Pharmaceutical Co., Ltd. | 8 | 2015-08-01 | 2016-01-11 |
| A Study of Continuous Endostar Intravenous Infusion Combined With Pemetrexed and Carboplatin in Advanced Non Small Cell Lung Cancer Patients Carboplatin, Pemetrexed, Endostar - Non-Small Cell Lung Cancer | Phase 1 | Completed | Jiangsu Simcere Pharmaceutical Co., Ltd. | 19 | 2011-09-01 | 2013-01-16 |
| Recombinant Human Endostatin in Combination With mFOLFOX6 in Patients With Metastatic Colorectal Cancer recombinant human endostatin (Endostat) - Colorectal Neoplasm | Phase 1 | Unknown | Fudan University | 15 | 2010-08-01 | 2011-03-08 |
Carcinoma, Non-Small-Cell Lung (2) · Colorectal Neoplasms (1)
Jiangsu Simcere Pharmaceutical Co., Ltd. (3) · Fudan University (1)
China (4)
Jia Chen, MD (1) · Jin Li, MD (1) · Li Zhang, MD (1) · Lingxiang Chen, MD (1)